Guangyu Biomedical Technology (Suzhou) Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2022

Location

Suzhou Jiangsu China

Primary Industry

Biotechnology

About

Based in Suzhou, China, and founded in 2022, Guangyu Biomedical Technology (Suzhou) Co., Ltd. is a biotech company that focuses on developing an in-vivo flow cytometer (IVFC). In August 2022, Guangyu Biomedical Technology (Suzhou) Co., Ltd. angel funding from Weidu Capital. The company self-developed in-vivo flow cytometer (IVFC) which enables blood-free, real-time, dynamic, continuous, non-invasive, quantitative detection/monitoring of target substances such as cells, molecules, and nanoparticles in the circulatory system of humans or animals, and reflects the real molecular, physiological, metabolic, and drug parameters and states of the human or experimental animal's internal environment. The technology is widely used for unlabeled pan-tumor species CTC (Circulating Tumor Cell), immune cells, stem cells, platelets, drug molecules, lipid molecules, nanoparticles, and therapeutic light capture CTC, light therapy for Parkinson's disease. The company plans to its proceeds from August 2022 funding for the research and development and clinical technology innovation for bulk flow cytometry products.

Current Investors

Weidu Capital

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.